Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–2 of 2 results
Advanced filters: Author: "M. Kaufman" Clear advanced filters
  • Recent advances in genotyping technology have identified or confirmed more than 20 loci that are associated with susceptibility to systemic lupus erythematosus (SLE). These findings add detail to our current understanding of the molecular basis of this complex disease and provide new avenues for investigation.

    • Isaac T. W. Harley
    • Kenneth M. Kaufman
    • Jennifer A. Kelly
    Reviews
    Nature Reviews Genetics
    Volume: 10, P: 285-290
  • The VEGFR small-molecule inhibitors of angiogenesis show promise for oncology patients. These rationally designed inhibitors are being tailored for use in specific malignancies and will have a pivotal role in personalized medicine. The authors discuss the potential of these agents for treating tumors such as metastatic renal-cell carcinoma, GIST and hepatocellular carcinoma.

    • S. Percy Ivy
    • Jeannette Y. Wick
    • Bennett M. Kaufman
    Reviews
    Nature Reviews Clinical Oncology
    Volume: 6, P: 569-579